Access full Report @ World In Vitro Diagnostics - Market Opportunities and Forecasts, 2015 - 2022
In vitro diagnostics (IVD) is the technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues and other body fluids, which are derived from the human body to detect diseases, conditions and infections. The tests can be performed in stand-alone laboratory, hospital based laboratory and point of care. Some of the significant technologies incorporated in vitro diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.
The world in vitro diagnostics market is estimated to garner $81.3 billion by 2022, registering a CAGR of 4.9% over the forecast period. Growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalised medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In addition, increasing incidences of colorectal cancer, neurological disorders, gynaecological diseases and others would boost the adoption of IVD devices and reagents. On the contrary, stringent government regulations and unfavourable reimbursement policies would limit the growth of the market. The rising demand for technologically advanced diagnostic devices and increased disposable income of consumers provides huge growth potential for IVD market.
The report segments the market across different categories such as product type, techniques, application, end users and geography. Based on product types, the market is segmented into reagents, instruments, and services & software. Based on techniques, the market is segmented into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry and other clinical techniques. Similarly, based on indication, the market is further segmented into, infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal disorders and other indications. Based on end users, the market is categorised into standalone laboratory, hospitals academics & medical schools and others. The geographical breakdown and detailed analysis of each of the aforesaid segments are included for North America, Europe, Asia-Pacific and LAMEA.
Companies are adopting acquisition and partnership as key development strategies in this market Roche diagnostics, Abbott, Danaher Corporation are few of the dominant players in the IVD market. Other companies include Johnson and Johnson, Sysmex Corporation, Becton Dickinson, bioMrieux, Thermo Fisher Scientific, Inc., Ortho-Clinical Diagnostics, Siemens AGand Alere Inc. The comprehensive competitive analysis and profiles of major market players mentioned above are profiled in the report.
KEY BENEFITS FOR STAKEHOLDERS:
This report provides an extensive analysis of the current and emerging trends and dynamics in the world IVD market.
Geographically, the world IVD market is analyzed based on various regions such as North America, Europe, Asia-Pacific and LAMEA.
This report entails the detailed quantitative analysis of the current market and estimations from 2015 to 2022, which assists in identifying the prevailing market opportunities.
Exhaustive analysis of the world IVD market by techniques helps in understanding the variants of IVD testing techniques that will gain prominence in the future.
Competitive intelligence highlights the business practices followed by leading market players across various geographies.
SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.
IVD MARKET KEY SEGMENTS:
By Product type
Software & Services
Other Clinical Techniques
Immune System Disorders
By End Users
Academic & Medical Schools
Request for Sample page @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=415222
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2027
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies
3.3 Porter five forces analysis
3.3.1 Bargaining power of supplier
3.3.2 Bargaining power of buyers
3.3.3 Low threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry
3.4 Government regulations
3.5 Value chain analysis
3.6 Case studies
3.6.1 Case Study 1: Positioning of new IVD Platform by Life Science
3.6.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system
3.7 Research & Analysis
3.7.1 Clinical Trials of research studies conducted for IVD market
3.8 Significant Progressions in IVD technologies
3.8.1 Total Laboratory Automation (TLA)
3.8.2 Evolving markets in digital pathology
3.8.3 Omics and Genetics tests in IVD
3.8.4 Point-of-Care testing
3.8.5 Emerging technologies diagnostics and influence on IVD
3.9 Market dynamics
220.127.116.11 Increasing incidences of chronic and infectious diseases
18.104.22.168 Technological advancements in IVD
22.214.171.124 Emergence of minimal invasive technologies
126.96.36.199 Increasing government expenditures on healthcare
188.8.131.52 Increase in popularity personalized medicine approach
184.108.40.206 Unclear reimbursement policies
220.127.116.11 Stringent Regulatory policies
18.104.22.168 Potential Opportunities for outsourcing
22.214.171.124 Convergence of new Technologies.
Purchase a licensed copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=371677
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
P: +44 208 133 9349
M: +1 646 845 9349